Breadcrumb
NIH Guide: Weekly Index for July 24, 2020
Weekly NIH Funding Opportunities and Notices
July 24, 2020
Policy Notices
-
AHRQ Grant Recipient use of the eRA Commons to Submit First-Time No-Cost Extension (NCE) Notifications for Grant Awards that are under Expanded Authorities
(NOT-HS-20-012)Agency for Healthcare Research and Quality
-
Notice to Extend PA-17-246
(NOT-HS-20-013)Agency for Healthcare Research and Quality
General Notices
-
Notice of Pre-Application Webinar for Developmental Genotype-Tissue Expression Project (dGTEx)
(NOT-HG-20-052)National Human Genome Research Institute
-
Request for Information (RFI) on Flexibilities for Conducting Semiannual Animal Facility Inspections
(NOT-OD-20-145)National Institutes of Health
Notice of Changes to Funding Opportunities
-
Notice of Early Expiration of PAR-20-269 Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)
(NOT-AG-20-044)National Institute on Aging
-
Notice of Change to Key Dates and Post Submission Materials Guideline in RFA-CA-20-033, "SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)"
(NOT-CA-20-087)National Cancer Institute
-
Notice of Change to Award Information in PAR-19-242, Paul Calabresi Career Development for Clinical Oncology (K12 Clinical Trial Optional)
(NOT-CA-20-088)National Cancer Institute
-
Notice of Correction to PAR-20-221, "NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)"
(NOT-DA-20-066)National Institute on Drug Abuse
-
Notice of Change to the Application Instructions for the Candidate Eligibility Statement in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)"
(NOT-GM-20-038)National Institute of General Medical Sciences
-
Notice to Reduce the Number of Research Projects Required in PAR-19-313 "Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional)"
(NOT-GM-20-042)National Institute of General Medical Sciences
-
Notice to Reduce the Number of Research Projects Required in PAR-19-312 "Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 Clinical Trial Optional)"
(NOT-GM-20-043)National Institute of General Medical Sciences
-
Notice of NHLBI Participation in NOT-OD-20-097 "Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences"
(NOT-HL-20-799)National Heart, Lung, and Blood Institute
-
Notice of Expiration of NOT-HL-20-782 "Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials"
(NOT-HL-20-800)National Heart, Lung, and Blood Institute
-
Notice of NHLBI Participation in NOT-MH-20-053 "NOSI regarding Availability of Admin Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences
(NOT-HL-20-801)National Heart, Lung, and Blood Institute
-
RESCINDED - Notice of NHLBI Participation in NOT-OD-20-119 "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"
(NOT-HL-20-803)National Heart, Lung, and Blood Institute
-
RESCINDED - Notice of NHLBI Participation in NOT-OD-20-120 "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"
(NOT-HL-20-804)National Heart, Lung, and Blood Institute
-
RESCINDED - Notice of NHLBI Participation in NOT-OD-20-121 "Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"
(NOT-HL-20-805)National Heart, Lung, and Blood Institute
-
Notice of Change: Extension to end date for NOT-OD-20-130 RFI: Enhancing Rigor, Transparency, and Translatability to Improve Biomedical Research Involving Animal Models
(NOT-OD-20-142)National Institutes of Health
-
Notice of Change: Clarification of Budget for PA-20-227 "Administrative Supplements for Research on Dietary Supplements (Admin Supp Clinical Trial Not Allowed)"
(NOT-OD-20-148)Office of Dietary SupplementsNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentJohn E. Fogarty International CenterNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute on Minority Health and Health DisparitiesDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for New Cohorts to Assess Environmental Exposures and Cancer Risk (UG3/UH3 Clinical Trial Optional)
(NOT-CA-20-086)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for a Coordinating Center for New Cohorts to Assess Environmental Exposures and Cancer Risk (U24 Clinical Trial Not Allowed)
(NOT-CA-20-091)National Cancer Institute
Requests for Proposal
-
Request for Proposal (RFP) Notice: NHLBI Progenitor Cell Translational Consortium (PCTC) - Scientific Services to Conduct In-depth Cell Characterization for the NIH Regenerative Medicine Innovation Project 2020
(NOT-HL-20-798)National Heart, Lung, and Blood Institute
Notices of Special Interest
-
Notice of Special Interest: Fundamental and Translational Research on Decision Making in Aging and/or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD)
(NOT-AG-20-039)National Institute on Aging
-
Notice of Special Interest (NOSI): Improving Methods to Assess Body Composition in Infants and Young Children
(NOT-DK-20-036)National Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Biomedical Imaging and Bioengineering
Funding Opportunities
-
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
(PAR-20-271)National Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Institute of Mental HealthApplication Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 5, 2020
-
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
(PAR-20-276)National Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Human Genome Research InstituteApplication Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 5, 2020
-
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
(PAR-20-277)National Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Human Genome Research InstituteApplication Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 16, 2020
-
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
(PAR-20-278)National Cancer InstituteApplication Receipt Date(s): November 6, 2020
-
Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional)
(PAR-20-281)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Cancer InstituteNational Institute of Environmental Health SciencesOffice of Research on Women's HealthOffice of Disease PreventionApplication Receipt Date(s): October 19, 2020, June 19, 2021, February 19, 2022, October 19, 2022, June 19, 2023
-
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed)
(PAR-20-282)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Cancer InstituteNational Institute of Environmental Health SciencesOffice of Research on Women's HealthOffice of Disease PreventionApplication Receipt Date(s): October 19, 2020, June 19, 2021, February 19, 2022, October 19, 2022, June 19, 2023
-
Limited Competition for the Continuation of the Look AHEAD (Action for Health in Diabetes) Study (U01 Clinical Trial Not Allowed)
(RFA-AG-21-028)National Institute on AgingApplication Receipt Date(s): October 30, 2020
-
Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Field Epidemiology Sites (U01 - Clinical Trial Not Allowed)
(RFA-DK-20-017)National Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesJohn E. Fogarty International CenterApplication Receipt Date(s): November 10, 2020
-
Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium Renal Science Core (U01 - Clinical Trial Not Allowed)
(RFA-DK-20-018)National Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesApplication Receipt Date(s): November 10, 2020
-
Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Scientific Data Coordinating Center (SDCC) (U24 - Clinical Trial Not Allowed)
(RFA-DK-20-019)National Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesApplication Receipt Date(s): November 10, 2020
-
NIEHS Research Intensive Short Courses and Educational Opportunities (NIEHS RISE) (R25 Clinical Trial Not Allowed)
(RFA-ES-20-015)National Institute of Environmental Health SciencesApplication Receipt Date(s): November 30, 2020, November 29, 2021, November 28, 2022
-
Extension of the World Trade Center Health Registry (U50)
(RFA-OH-21-003)National Institute for Occupational Safety and HealthApplication Receipt Date(s): December 13, 2020
-
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Hubs (U54 Clinical Trial Optional)
(RFA-RM-20-015)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): December 8, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Training Program (U2R Clinical Trial Optional)
(RFA-RM-20-016)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): December 18, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Ethical, Legal, and Social Implications Research (U01 Clinical Trial Not Allowed)
(RFA-RM-20-017)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): December 1, 2020
-
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Open Data Science Platform and Coordinating Center (U2C Clinical Trial Not Allowed)
(RFA-RM-20-018)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): December 3, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: February 11, 2025
For technical issues E-mail OER Webmaster